{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:18:46Z","timestamp":1792019926651,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lipoprotein(a) is genetically determined and increasingly recognized as a major risk factor for arteriosclerotic cardiovascular disease. We examined whether plasma lipoprotein(a) concentrations were associated with intraplaque neovascularization (IPN) grade in patients with carotid stenosis and in terms of increasing plaque susceptibility to haemorrhage and rupture.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We included 85 patients diagnosed with carotid stenosis as confirmed using carotid ultrasound who were treated at Guangdong General Hospital. Baseline data, including demographics, comorbid conditions and carotid ultrasonography, were recorded. The IPN grade was determined using contrast-enhanced ultrasound through the movement of the microbubbles. Univariate and multivariate binary logistic regression analyses were used to evaluate the association between lipoprotein(a) and IPN grade, with stepwise adjustment for covariates including age, sex, comorbid conditions and statin therapy (model 1), total cholesterol, triglyceride, low-density lipoprotein cholesterol calculated by Friedwald's formula, high-density lipoprotein cholesterol, apolipoprotein A and apolipoprotein B (model 2), maximum plaque thickness and total carotid maximum plaque thickness, degree of carotid stenosis and internal carotid artery (ICA) occlusion (model 3).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Lipoprotein(a) was a significant predictor of higher IPN grade in binary logistic regression before adjusting for other risk factors (odds ratio [OR] 1.238, 95% confidence interval [CI] (1.020, 1.503), <jats:italic>P<\/jats:italic>\u2009=\u20090.031). After adjusting for other risk factors, lipoprotein(a) still remained statistically significant in predicting IPN grade in all model. (Model 1: OR 1.333, 95% CI 1.074, 1.655, <jats:italic>P<\/jats:italic>\u2009=\u20090.009; Model 2: OR 1.321, 95% CI 1.059, 1.648, <jats:italic>P<\/jats:italic>\u2009=\u20090.014; Model 3: OR 1.305, 95% CI 1.045, 1.628, <jats:italic>P<\/jats:italic>\u2009=\u20090.019). Lp(a)\u2009\u2265\u2009300\u00a0mg\/L is also significantly related to IPN compare to\u2009&lt;\u2009300\u00a0mg\/L (OR 2.828, 95% CI 1.055, 7.580, <jats:italic>P<\/jats:italic>\u2009=\u20090.039) as well as in model 1, while in model 2 and model 3 there are not significant difference.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Plasma lipoprotein(a) concentrations were found to be independently associated with higher IPN grade in patients with carotid stenosis. Lowering plasma lipoprotein(a) levels may result in plaque stabilization by avoiding IPN formation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-02038-x","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T15:04:10Z","timestamp":1623251050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The association of lipoprotein(a) and intraplaque neovascularization in patients with carotid stenosis: a retrospective study"],"prefix":"10.1186","volume":"21","author":[{"given":"Shuang","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weida","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"issue":"2","key":"2038_CR1","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3174\/ajnr.A5488","volume":"39","author":"L Saba","year":"2018","unstructured":"Saba L, Yuan C, Hatsukami TS, Balu N, Qiao Y, DeMarco JK, et al. Carotid artery wall imaging: perspective and guidelines from the ASNR Vessel Wall Imaging Study Group and Expert Consensus Recommendations of the American Society of Neuroradiology. AJNR Am J Neuroradiol. 2018;39(2):E9\u201331.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2038_CR2","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jcmg.2010.09.017","volume":"3","author":"C Giannarelli","year":"2010","unstructured":"Giannarelli C, Ibanez B, Cimmino G, Garcia Ruiz JM, Faita F, Bianchini E, et al. Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis. JACC Cardiovasc Imaging. 2010;3:1256\u201364.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"2038_CR3","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/STROKEAHA.119.025496","volume":"50","author":"M Zamani","year":"2019","unstructured":"Zamani M, Skagen K, Scott H, Lindberg B, Russell D, Skjelland M. Carotid plaque neovascularization detected with superb microvascular imaging ultrasound without using contrast media. Stroke. 2019;50(11):3121\u20137.","journal-title":"Stroke"},{"issue":"11","key":"2038_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/ehjci\/jez070","volume":"20","author":"LE Mantella","year":"2019","unstructured":"Mantella LE, Colledanchise KN, H\u00e9tu MF, Feinstein SB, Abunassar J, Johri AM. Carotid intraplaque neovascularization predicts coronary artery disease and cardiovascular events. Eur Heart J Cardiovasc Imaging. 2019;20(11):1239\u201347.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2038_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2018.06.863","volume":"275","author":"EM Ooi","year":"2018","unstructured":"Ooi EM, Ellis KL, Barrett PHR, Watts GF, Hung J, Beilby JP, et al. Lipoprotein(a) and apolipoprotein(a) isoform size: associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque. Atherosclerosis. 2018;275:232\u20138.","journal-title":"Atherosclerosis"},{"key":"2038_CR6","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/ATVBAHA.108.169292","volume":"28","author":"JH Klein","year":"2008","unstructured":"Klein JH, Hegele RA, Hackam DG, Koschinsky ML, Huff MW, Spence JD. Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area. Arterioscler Thromb Vasc Biol. 2008;28:1851\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2038_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1161\/ATVBAHA.117.310368","volume":"38","author":"DS Hippe","year":"2018","unstructured":"Hippe DS, Phan BAP, Sun J, Isquith DA, O\u2019Brien KD, Crouse JR, Anderson T, Huston J, Marcovina SM, Hatsukami TS, Yuan C, Zhao X-Q. Lp(a) (Lipoprotein(a)) levels predict progression of carotid atherosclerosis in subjects with atherosclerotic cardiovascular disease on intensive lipid therapy: an analysis of the AIM-HIGH (Atherothrombosis intervention in metabolic syndrome with low HDL\/high triglycerides: impact on Global Health Outcomes) carotid magnetic resonance imaging substudy-brief report. Arterioscler Thromb Vasc Biol. 2018;38:673\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2038_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1155\/2013\/563717","volume":"35","author":"A Cai","year":"2013","unstructured":"Cai A, Li L, Zhang Y, Mo Y, Mai W, Zhou Y. Lipoprotein(a): a promising marker for residual cardiovascular risk assessment. Dis Markers. 2013;35:551\u20139.","journal-title":"Dis Markers"},{"key":"2038_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/01.ATV.21.3.433","volume":"21","author":"V Schulter","year":"2001","unstructured":"Schulter V, Koolwijk P, Peters E, Frank S, Hrzenjak A, Graier WF, van Hinsbergh VW, Kostner GM. Impact of apolipoprotein(a) on in vitro angiogenesis. Arterioscler Thromb Vasc Biol. 2001;21:433\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2038_CR10","doi-asserted-by":"publisher","first-page":"e52287","DOI":"10.1371\/journal.pone.0052287","volume":"8","author":"L Liu","year":"2013","unstructured":"Liu L, Boffa MB, Koschinsky ML. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system. PLoS ONE. 2013;8:e52287.","journal-title":"PLoS ONE"},{"key":"2038_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1042\/BJ20080744","volume":"418","author":"L Liu","year":"2009","unstructured":"Liu L, Craig AW, Meldrum HD, Marcovina SM, Elliott BE, Koschinsky ML. Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin alphaVbeta3. Biochem J. 2009;418:325\u201336.","journal-title":"Biochem J"},{"key":"2038_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1006\/exmp.1998.2230","volume":"65","author":"XJ Lou","year":"1998","unstructured":"Lou XJ, Kwan HH, Prionas SD, Yang ZJ, Lawn RM, Fajardo LF. Despite its homology to angiostatin apolipoprotein(a) does not affect angio-genesis. Exp Mol Pathol. 1998;65:53\u201363.","journal-title":"Exp Mol Pathol"},{"key":"2038_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000343145","volume":"34","author":"P-J Touboul","year":"2012","unstructured":"Touboul P-J, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Hernandez Hernandez R, Jaff M, Kownator S, Naqvi T, Prati P, Rundek T, Sitzer M, Schminke U, Tardif J-C, Taylor A, Vicaut E, Woo KS. Mannheim carotid intima-media thickness and plaque consensus (2004\u20132006\u20132011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34:290\u20136.","journal-title":"Cerebrovasc Dis"},{"key":"2038_CR14","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jacc.2010.11.005","volume":"57","author":"TG Brott","year":"2011","unstructured":"Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, Hertzberg VS, McIff EB, Moore WS, Panagos PD, Riles TS, Rosenwasser RH, Taylor AJ. 2011ASA\/ACCF\/AHA\/AANN\/AANS\/ACR\/ASNR\/CNS\/SAIP\/SCAI\/SIR\/SNIS\/SVM\/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. J Am Coll Cardiol. 2011;57:1002\u201344.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2038_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ejvs.2015.06.077","volume":"50","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Li C, Han H, Dai W, Shi J, Wang Y, et al. Spatio-temporal quantification of carotid plaque neovascularization on contrast enhanced ultrasound: correlation with visual grading and histopathology. Eur J Vasc Endovasc Surg. 2015;50(3):289\u201396.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"2038_CR16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jcmg.2015.07.026","volume":"9","author":"BN Shah","year":"2016","unstructured":"Shah BN, Gujral DM, Chahal NS, Harrington KJ, Nutting CM, Senior R. Plaque neovascularization is increased in human carotid atherosclerosis related to prior neck radiotherapy: a contrast-enhanced ultrasound study. JACC Cardiovasc Imaging. 2016;9(6):668\u201375.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"2038_CR17","first-page":"750","volume":"12","author":"Y Kan","year":"2019","unstructured":"Kan Y, He W, Ning B, Li HX, Wei SJ, Yu TF. The correlation between calcification in carotid plaque and stroke: calcification may be a risk factor for stroke. Int J Clin Exp Pathol. 2019;12(3):750\u20138.","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"2038_CR18","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1161\/STROKEAHA.115.009910","volume":"46","author":"C Gr\u00f6nberg","year":"2015","unstructured":"Gr\u00f6nberg C, Bengtsson E, Fredrikson GN, Nitulescu M, Asciutto G, Persson A, et al. Human carotid plaques With high levels of interleukin-16 are associated With reduced risk for cardiovascular events. Stroke. 2015;46(10):2748\u201354.","journal-title":"Stroke"},{"issue":"2","key":"2038_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/echo.13007","volume":"33","author":"AM Johri","year":"2016","unstructured":"Johri AM, Behl P, H\u00e9tu MF, Haqqi M, Ewart P, Day AG, et al. Carotid ultrasound maximum plaque height-A sensitive imaging biomarker for the assessment of significant coronary artery disease. Echocardiography. 2016;33(2):281\u20139.","journal-title":"Echocardiography"},{"issue":"9197","key":"2038_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0140-6736(99)04470-0","volume":"355","author":"PM Rothwell","year":"2000","unstructured":"Rothwell PM, Villagra R, Gibson R, Donders RC, Warlow CP. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet. 2000;355(9197):19\u201324.","journal-title":"Lancet"},{"issue":"3","key":"2038_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000319065","volume":"30","author":"B Boden-Albala","year":"2010","unstructured":"Boden-Albala B, Kargman DE, Lin IF, Paik MC, Sacco RL, Berglund L. Increased stroke risk and lipoprotein(a) in a multiethnic community: The Northern Manhattan Stroke Study. Cerebrovasc Dis. 2010;30(3):237\u201343.","journal-title":"Cerebrovasc Dis"},{"key":"2038_CR22","doi-asserted-by":"publisher","first-page":"104858","DOI":"10.1016\/j.phrs.2020.104858","volume":"158","author":"V Kalaivani","year":"2020","unstructured":"Kalaivani V, Jaleel A. Apolipoprotein(a), an enigmatic anti-angiogenic glycoprotein in human plasma: a curse or cure? Pharmacol Res. 2020;158:104858.","journal-title":"Pharmacol Res"},{"key":"2038_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbrc.2012.05.086","volume":"423","author":"M Iwabayashi","year":"2012","unstructured":"Iwabayashi M, Taniyama Y, Sanada F, Azuma J, Iekushi K, Okayama K, Chatterjee A, Rakugi H, Morishita R. Inhibition of Lp(a)-induced functional impairment of endothelial cells and endothelial progenitor cells by hepatocyte growth factor. Biochem Biophys Res Commun. 2012;423:79\u201384.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2038_CR24","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.3390\/jcm9072103","volume":"9","author":"MF Greco","year":"2020","unstructured":"Greco MF, Sirtori CR, Corsini A, Ezhov M, Sampietro T, Ruscica M. Lipoprotein(a) lowering-from lipoprotein apheresis to antisense oligonucleotide approach. J Clin Med. 2020;9(7):2103.","journal-title":"J Clin Med"},{"key":"2038_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jacc.2019.10.057","volume":"75","author":"VA Bittner","year":"2020","unstructured":"Bittner VA, Szarek M, Aylward PE, et al. Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome. J Am Coll Cardiol. 2020;75:133\u201344.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2038_CR26","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.amjcard.2014.05.060","volume":"114","author":"D Gaudet","year":"2014","unstructured":"Gaudet D, Kereiakes DJ, McKenney JM, Roth EM, Hanotin C, Gipe D, et al. Effect of alirocumab, a monoclonal proprotein convertase subtilisin\/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials). Am J Cardiol. 2014;114(5):711\u20135.","journal-title":"Am J Cardiol"},{"issue":"4","key":"2038_CR27","doi-asserted-by":"publisher","first-page":"e010932","DOI":"10.1161\/JAHA.118.010932","volume":"8","author":"MD Shapiro","year":"2019","unstructured":"Shapiro MD, Minnier J, Tavori H, Kassahun H, Flower A, Somaratne R, et al. Relationship Between low-density lipoprotein cholesterol and lipoprotein(a) lowering in response to PCSK9 inhibition With evolocumab. J Am Heart Assoc. 2019;8(4):e010932.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2038_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.amjcard.2016.09.010","volume":"119","author":"D Gaudet","year":"2017","unstructured":"Gaudet D, Watts GF, Robinson JG, Minini P, Sasiela WJ, Edelberg J, et al. Effect of alirocumab on lipoprotein(a) over \u22651.5 years (from the Phase 3 ODYSSEY Program). Am J Cardiol. 2017;119(1):40\u20136.","journal-title":"Am J Cardiol."},{"issue":"6","key":"2038_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10557-019-06906-9","volume":"33","author":"MF Wu","year":"2019","unstructured":"Wu MF, Xu KZ, Guo YG, Yu J, Wu Y, Lin LM. Lipoprotein(a) and atherosclerotic cardiovascular disease: current understanding and future perspectives. Cardiovasc Drugs Ther. 2019;33(6):739\u201348.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"2038_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa1905239","volume":"382","author":"S Tsimikas","year":"2020","unstructured":"Tsimikas S, Karwatowska-Prokopczuk E, Gouni-Berthold I, Tardif J-C, Baum SJ, Steinhagen-Thiessen E, Shapiro MD, Stroes ES, Moriarty PM, Nordestgaard BG, Xia S, Guerriero J, Viney NJ, Dea L, Witztum JL. AKCEA-APO(a)-LRx Study Investigators. Lipoprotein(a) reduction in persons with cardiovascular disease. N Engl J Med. 2020;382(3):244\u201355.","journal-title":"N Engl J Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02038-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02038-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02038-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T15:05:15Z","timestamp":1623251115000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02038-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2038"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02038-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"28 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective investigation was approved by the Research Ethics Committee of Guangdong General Hospital, Guangdong Academy of Medical Sciences. [No. GDREC2017172h]. Each participant provides written informed consent to collect all data before the study and was anonymized before analyses.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"285"}}